Skip to search formSkip to main contentSkip to account menu
Residual symptoms in depressed patients who respond acutely to fluoxetine.
TLDR
The high prevalence of residual symptoms among antidepressant responders suggests the need for further study including whether residual symptoms abate with longer treatment or increased dose of fluoxetine.
View on PubMed
Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.
TLDR
It is suggested that MBSR may have a beneficial effect on anxiety symptoms in GAD and may also improve stress reactivity and coping as measured in a laboratory stress challenge.
View on PubMed
Timing of onset of antidepressant response with fluoxetine treatment.
TLDR
Assessment of time until onset of antidepressant response with fluoxetine treatment with outpatients with major depression suggests that more than half of eventual responders to fluoxettine treatment at 8 weeks start to respond by week 2; over 75% start to responded by week 4.
View on PubMed
Chronic Trichuris muris Infection in C57BL/6 Mice Causes Significant Changes in Host Microbiota and Metabolome: Effects Reversed by Pathogen Clearance
TLDR
Infection of T. muris causes a significant and substantial impact on intestinal microbiota and digestive function of mice with affects in long term immune regulation.
View PDF
A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia.
View on PubMed
Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
TLDR
Results support the safety and efficacy of sertraline for the short-term treatment of patients with panic disorder.
View on PubMed
Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation
View on PubMed
A double‐blind study of the efficacy of venlafaxine extended‐release, paroxetine, and placebo in the treatment of panic disorder
TLDR
Venlafaxine ER and paroxetine were effective and well tolerated in the treatment of panic disorder and Intent‐to‐treat, last observation carried forward analysis showed that mean improvement on most measures was greater with venlafAXine ER or paroxETine than with placebo.
View on Wiley
TGFβ: a sleeping giant awoken by integrins.
View on PubMed
Olanzapine Augmentation of Fluoxetine for Refractory Generalized Anxiety Disorder: A Placebo Controlled Study
View on Elsevier
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License